Intuitive Surgical, Inc. (ISRG) Stock Price Today
Aura AI Summary
Key Stats
- $153.77BMarket Cap
- 1,595,224Volume
- HealthSector
- $592.8552W High
- $332.0252W Low
- 85 DaysTypical Hold Time
- $149.73BEnterprise Value
- -Div Yield
- -Trading Activity
Track Intuitive Surgical, Inc. (ISRG) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Intuitive Surgical, Inc. has traded between a low of $332.02 and a high of $592.85, highlighting its annual price range. Buy and sell Intuitive Surgical, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Most Recent News
DeGen Medical moves to dismiss Carlsmed's patent suit over spinal implant methods.
DeGen Medical has filed a motion to dismiss key parts of a patent infringement lawsuit from Carlsmed, which claims DeGen's patient-specific spinal implants infringe on eight patents. DeGen argues that the contested patents cover abstract, computer-im...

China includes Ascentage Pharma's lisaftoclax and renews olverembatinib coverage in 2026 National Reimbursement Drug List
Ascentage Pharma announced that its cancer drugs lisaftoclax and olverembatinib are now covered by China's 2026 National Reimbursement Drug List (NRDL), effective January 1, 2027. Lisaftoclax is newly included for treating chronic lymphocytic leukemi...

All patients in Alpha Tau's glioblastoma trial alive with 100% tumor response and no serious side effects
Alpha Tau Medical announced interim results from its U.S. trial of Alpha DaRT therapy for recurrent glioblastoma, showing all eight treated patients are alive with a median follow-up of 6.9 months and no median survival reached. Among six patients as...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.